Coronavirus (COVID-19)
Learn more
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction Who Have Been Stabilized During Hospitalization for Acute Heart Failure
Dr. Jaiswal and Hartford Hospital’s Heart Failure Department are enrolling patients in this international trial for patients with heart failure and reduced ejection fraction who will be randomized to dapagliflozin versus placebo while in the hospital.
Eligibility Criteria:
Please contact Khadija El Aoudi at 860-972-3167 or by email at Khadija.elaoudi@hhchealth.org for more information.
Backus Hospital
Charlotte Hungerford Hospital
Hartford Hospital
The Hospital of Central Connecticut
MidState Medical Center
St. Vincent’s Medical Center
Windham Hospital
View all Medical Group Locations
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209